UVA SCHOOL OF MEDICINE TEAMS WI
“The School has a commitment to engage in explorations at the frontiers of medicine and science. Our partnerships with AstraZeneca, Merck, and St. Bartolo Hospital have the potential to extend our discoveries into useful medicine.”
– Steven T. DeKosky Vice President and Dean UVA School of Medicine
Partnership with AstraZeneca to Target Cardiovascular Disease
The University of Virginia and AstraZeneca are collaborating on the development of new treatments – primarily for coronary artery disease, with a secondary focus on peripheral vascular disease.
“We are working with AstraZeneca to advance the science of cardiovascular research,” says Gary Owens, director of UVA’s Robert M. Berne Cardiovascular Research Center and principal investigator of the AstraZeneca-UVA Alliance. “Our partnership has the potential to greatly speed up the development of novel drugs to treat diseases in several targeted areas, moving these projects years ahead in many cases.”
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28